CD14 and cancer: Repeating the same type of analysis using P2, we observed that CD14 + monocytes were significantly decreased in pre-vaccine cancer samples compared to healthy (Supplementary Fig. 2a(i–iii)), with 13/36 clusters significantly different between healthy and pre-vaccine cancer.